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INTRODUCTION
It is well-established today that the success rate of opera-
tions for epilepsy reaches almost 85% (1-3). Preoperative eval-
uation of surgical candidates by F-18 fluorodeoxyglucose (F-
18 FDG) positron emission tomography (PET) and ictal
single-photon emission computed tomography (SPECT) has
become a routine practice. This review describes the diag-
nostic performance of F-18 FDG PET and ictal perfusion
SPECT in intractable epilepsies using the more recent image
processing methods based on technological advancements as
applied to brain F-18 FDG PET and ictal SPECT.
A review of the literature published in 1995, regarding
the diagnostic performance of various imaging methods to
find epileptogenic zones, showed the variable sensitivity of
the several methods used in temporal lobe and extratempo-
ral lobe epilepsies (4). The diagnostic accuracy of interictal
SPECT from this data seems to be overestimated because
another meta-analysis conducted in 1998 (5) revealed that
the overall sensitivity of interictal SPECT was 44%. Until
1995, the sensitivity of FDG PET was not particularly high
especially in the case of extratemporal epilepsy; however, re-
cent progress has increased the sensitivity.
The diagnostic performance for medial temporal lobe
epilepsy is different from that for extratemporal neocortical
epilepsy (4-7). Lateral temporal lobe epilepsy falls into the
group of extratemporal lobe epilepsy (2). According to a meta-
analysis (5), the cumulative sensitivity of ictal SPECT was
97% in medial temporal lobe epilepsy. This meta-analysis
also reported that the sensitivity of ictal SPECT in extratem-
poral lobe epilepsy is still elusive because of a lack of avail-
able data.
The sensitivity of ictal perfusion SPECT, FDG PET, and
MRI in intractable epilepsy at our institution is shown in
Table 1 (8). At the end of 1997, among more than 300 pa-
tients studied, 118 were operated and followed up for more
than a year. This group included temporal lobe and extra-
temporal lobe epilepsy patients. As a whole, the sensitivity
of ictal SPECT was determined to be around 75% and that
of FDG PET was around 85%. In contrast, the sensitivity
of MRI was determined to be 70%.
DIAGNOSTIC PERFORMANCE OF FDG PET AND
ICTAL SPECT IN MEDIAL TEMPORAL LOBE
EPILEPSY
Medial temporal lobe epilepsy is well known for its patho-
logic diagnostic criteria of hippocampal sclerosis and/or atro-
phy. These hippocampal changes are easily found by the re-
cent generation MRI machines (Fig. 1A). Both the quanti-
tative and the qualitative MRI interpretation give similar
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Functional Neuroimaging in Epilepsy: FDG PET and Ictal SPECT
Epileptogenic zones can be localized by F-18 fluorodeoxyglucose positron emis-
sion tomography (FDG PET) and ictal single-photon emission computed tomog-
raphy (SPECT). In medial temporal lobe epilepsy, the diagnostic sensitivity of
FDG PET or ictal SPECT is excellent, however, the sensitivity of MRI is so high
that the incremental sensitivity by FDG PET or ictal SPECT has yet to be proven.
When MRI findings are ambiguous or normal, or discordant with those of ictal
EEG, FDG PET and ictal SPECT are helpful for localization without the need for
invasive ictal EEG. In neocortical epilepsy, the sensitivities of FDG PET or ictal
SPECT are fair. However, because almost a half of the patients are normal on
MRI, FDG PET and ictal SPECT are helpful for localization or at least for lateral-
ization in these non-lesional epilepsies in order to guide the subdural insertion of
electrodes. Interpretation of FDG PET has been recently advanced by voxel-
based analysis and automatic volume of interest analysis based on a population
template. Both analytical methods confirmed the performance of previous visual
interpretation results. Ictal SPECT was analyzed using subtraction methods
(coregistered to MRI) and voxel-based analysis. Rapidity of injection of tracers,
HMPAO versus ECD, and repeated ictal SPECT, which remain the technical
issues of ictal SPECT, are detailed.
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diagnostic effectiveness for temporal lobe epilepsy with the
recent generation MRI machines. Cases without any abnor-
mal findings on MRI exist but rare (9).
Thus, FDG PET is helpful only for three types of cases in
medial temporal lobe epilepsy. The first type is represented
by those patients with ambiguous sclerosis (Fig. 1B). In a
few patients with medial temporal lobe epilepsy, hippocam-
pal sclerosis is not prominent even on three-dimensional MP-
PAGE MR images. The second type is of bilateral sclerosis
and/or atrophy (Fig. 1C). A few confusing cases have been
filed among 600 fully-investigated epilepsy patients at our
institution. The third type is represented by those patients
with normal MRI findings (Fig. 1D). Ictal perfusion SPECT
is also helpful in these three types of cases (Fig. 2). FDG PET
and ictal SPECT were found to be similarly effective at local-
izing epileptogenic zones in non-lesional (MRI-negative)
medial temporal lobe epilepsy (9).
DIAGNOSTIC PERFORMANCE OF FDG PET 
AND ICTAL SPECT IN EXTRATEMPORAL LOBE
EPILEPSY
In contrast to the temporal lobe epilepsy, the extratempo-
ral lobe epilepsy poses several problems in terms of the local-
ization of epileptogenic zones. About one third to one half
of intractable patients are usually suspected to have extratem-
poral lobe epilepsy (10-12). Extratemporal lobe epilepsy con-
sists of lateral temporal, frontal, occipital and parietal lobe
epilepsy, in decreasing order of prevalence (11).
Extratemporal lobe epilepsy poses two kinds of problems
in localization of epileptogenic zones. The first is that if the
MRI shows multiple candidate foci of epileptogenic zones,
one cannot be sure which is the culprit lesion for the seizure
induction. The second is that if the MRI does not show any
structural lesion, that is to say, the lesion is cryptogenic, it is
difficult to determine where to apply subdural grids and strips
during subdural EEG studies. FDG PET and ictal SPECT
are helpful in these cases. They may make it clear that a lesion
is epileptogenic or localize a lesion in a totally cryptogenic
case. In some patients, FDG PET and ictal SPECT can at
least lateralize cryptogenic lesions, although cannot localize
a lesion.
According to our previous study (13), positive predictive
values of FDG PET and ictal SPECT in cryptogenic epilep-
Modified from reference 8
Pathology Surgical Outcome
MRI 72% 77%
F-18-FDG PET 85% 86%
Ictal SPECT 73% 78%
Table 1. Correct localization of MR, F-18 FDG PET, and ictal
SPECT
Fig. 1. FDG PET of medial temporal lobe epilepsy. (A) A typical
matching case with hippocampal atrophy and hypometabolism
in the left temporal lobe. (B) A case with ambiguous ictal EEG but
with definite hypometabolism in the right temporal lobe. (C) An
example of bilateral hippocampal atrophy on MRI but unilateral
hypometabolism in the right temporal lobe. (D) A non-lesional
cryptogenic case on MRI but with mild hypometabolism in the
right temporal lobe. All of these 4 patients underwent operations
and had surgical outcomes of Engel class 1.
A
C
B
D
Fig. 2. Ictal SPECT in a case with cryptogenic medial temporal
lobe epilepsy. MRI findings were normal. (A) Ictal hyperperfusion
is found in the left temporal lobe on ictal perfusion SPECT. (B)
Transaxial slice (C) Coronal view. Surgical outcome after left tem-
poral lobectomy was excellent.
A
C
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sy are over 70%. Localization rates are different for different
epileptogenic lobes. Among the complex partial seizure pa-
tients, lateral temporal lobe (Fig. 3) or frontal lobe seizures
(Fig. 4) are relatively easy to diagnose. On the contrary, it is
not easy to localize epileptogenic zones in occipital lobe
epilepsy. Areas showing the most severe hypometabolism
are limited to the occipital lobes in some patients (Fig. 5),
however, this is not true in all patients. The areas of highest
perfusion were not limited to occipital lobes, either. In some
patients, the hypometabolism was localized to the ipsilater-
al temporal lobes. Moreover, epileptogenic zones could have
been misdiagnosed for temporal lobes. As for the occipital
lobe epilepsy, the localization rate was found to be 47% by
MRI and 60% by PET (14). The localization rate of ictal
SPECT was not excellent, however, the lateralization rate of
ictal SPECT was 76%. This might have been caused by the
rapid propagation of ictal discharges from the occipital lobe
to adjacent lobes, especially to the temporal lobe. In confus-
ing cases of occipital lobe epilepsy, the examination of visual
symptoms and visual field is mandatory (14).
UNCOUPLING OF METABOLISM AND 
PERFUSION IN EPILEPTOGENIC ZONES
The sensitivity of interictal SPECT was 44% on average
according to a meta-analysis (5). However, in our cohort study
(13), the sensitivity was lower (34%) in temporal and extra-
Fig. 4. FDG PET and ictal SPECT in frontal lobe epilepsy. MRI is
normal (A), but localized decrease of metabolism is found in the
left frontal lobe (B). In another case, the MRI is normal (C), but
localized increased perfusion is found in the right frontal lobe (D).
After neocortical resection of the frontal lobe in both patients,
they were seizure free.
A
C
B
D
Fig. 5. FDG PET and ictal SPECT in occipital lobe epilepsy. MRI
was normal (A), but metabolism is decreased in a case of right
occipital lobe epilepsy (B). In another case, the MRI is normal
(C), but perfusion is increased in the left occipital lobe on ictal
SPECT (D). Both of the patients became seizure-free after neo-
cortical resection.
A
C
B
D
Fig. 3. FDG PET and ictal SPECT in lateral temporal lobe epilep-
sy. (A) An example of a lesional case with AV malformation on
MRI. (B) On FDG PET, the metabolism is decreased in the right
temporal lobe. (C) A cryptogenic case with normal hippocam-
pus and neocortex on MRI. Metabolism is lower on FDG PET in
the right temporal lobe. (D) Perfusion is increased on ictal SPECT
in the same case.
A
C
B
D692 D.S. Lee, S.K. Lee, M.C. Lee
temporal lobe epilepsy. When we consider the dogma of
metabolism and perfusion coupling in brain, the significance
of or the reason for this finding is important. The reason why
interictal FDG PET is excellent but interictal SPECT is poor
(Fig. 6) for the localization of epileptogenic zones could be
explained as follows.
Among more than 300 patients, we identified 14 patients
with increased perfusion in the epileptogenic zones as deter-
mined by surgical outcome or invasive studies (15). Four of
these were the patients in whom interictal SPECT was per-
formed on the second day after ictal study. In other four pa-
tients, seemingly hyperperfused, were studied on the 3rd to
5th day after ictal study (Fig. 7A, B). This means that the
interictal SPECT was in fact not the interictal one. Subclin-
ical seizure activity just before or during interictal studies
could have resulted in this increased perfusion at the epilep-
togenic zones.
On the other hand, delayed postictal perfusion abnormal-
ities even long after the previous ictus could have resulted
in the increased perfusion (16). When we performed delayed
postictal SPECT at 6 hr after ictal SPECT, we found remnant
hyperperfusion in a half of the patients (Fig. 7C-E). In one
patient, severe hypoperfusion was found on delayed postictal
SPECT, which recovered on interictal SPECT. Based upon
this investigation, we suggest that even with the EEG moni-
toring during interictal SPECT, one cannot be sure that the
true interictal SPECT has been obtained. 
VOXEL-BASED ANALYSIS OF FDG PET
Statistical parametric mapping (SPM) is a voxel-based ap-
proach for determining the significantly different area from
normal controls (Fig. 6). After spatially transforming and
smoothing the individual PET or SPECT data, using the
general linear model, the voxel count of the individual pa-
tient is compared with that of the normal controls. This
analysis method is easy to perform and very robust, and has
recently become popular (16-18).
QUANTIFICATION USING AUTOMATIC VOLUME
OF INTEREST ON POPULATION BASED ATLAS
This method is based on the population-based standard
anatomy, which was developed by Montreal Neurological
Institute and named SPAM. SPAM, an abbreviation for ‘sta-
Fig. 7. Hyperperfusion on interictal SPECT (A, B) and delayed
postictal hyperperfusion after ictus (C, D, E). In a patient with
surgically confirmed right temporal lobe epilepsy, interictal SPECT
(B) taken on the fourth day after ictal study (A), shows the same
increased perfusion in the right temporal lobe and crossed cere-
bellar hyperperfusion. (C, D, E) Delayed hyperperfusion at the
epileptogenic zones. In this patient with right temporal lobe epilep-
sy, perfusion is increased in the right temporal lobe on ictal SPECT
(C) and also in 6-hr delayed SPECT (D). On interictal SPECT (E),
perfusion is decreased in this temporal lobe (16).
A
C
E
B
D
Fig. 6. SPM analysis result of FDG PET and water PET (39). Col-
ored areas are the voxels that differ from the normal controls on
both PETs. In a coupled case, the left temporal lobe is found to
have hypometabolic voxels on FDG PET (A) and hypoperfused
voxels on water PET (B). In an uncoupled case, the right tempo-
ral lobe is found to have hypometabolic voxels on FDG PET (C),
however, there was no area of hypoperfusion on water PET (D).
Metabolism
rCBF
A
B
C
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tistical probabilistic anatomical map’ , differs from SPM. SPM
is a voxel-based approach, whereas SPAM is an area-based
approach. We have a population-averaged anatomical defi-
nition of gyri and lobes in MRI template format. To con-
struct SPAM, the Montreal group collected, parceled, and
segmented normal MR images from 152 young people. Orig-
inal PET images are transformed to an MRI template and
multiplied by the probabilities obtained from the SPAM
template. For example, if the right hippocampus is chosen,
the resulting image shows the counts in the probabilistic
area of the right hippocampus. This method was first used
by our group to quantify objectively the asymmetric index
and these asymmetric indices could be used to localize epilep-
togenic zones on FDG PET (19).
TECHNICAL ISSUES OF ICTAL SPECT
Rapidity of radiotracer injection
Ictal hyperperfusion is followed by postictal hypoperfusion
in epileptogenic zones. Whereas an ictal hyperperfusion could
be revealed if the injection is delayed within 60 sec of the
ictal EEG onset (20), the postictal perfusion decrease might
be observed if the injection is delayed within 2 to 15 min of
the ictal EEG onset. Postictal hypoperfusion in epileptogenic
zones has been used to help identify epileptogenic zones. The
semiology and EEG should be monitored with a video cam-
era equipped with a continuous EEG monitoring system just
to confirm the pertinence of ictal injection. Although referred
to by earlier studies, the onset of clinical ictus is frequently
different from that of ictal EEG. The latter is sure to be the
earlier of the two, and video-EEG monitoring is indispens-
able to determine the injection delay.
A recent report (21) analyzed the relationships between
the results of ictal SPECT and those of ictal EEG, placing an
emphasis on the possibility of false lateralization. Low con-
cordance rate was revealed to exist between peri-ictal EEG
and ictal SPECT when the preinjection and postinjection
epochs were different in terms of their lateralizations. Con-
sidering the spreading nature of ictal discharges associated
with increased cerebral perfusion, this result seems reason-
able, however we analyzed a larger group of patients (n=68)
than in the previous study (21) and found that preinjection
EEG, not postinjection EEG was significantly effective in
determining the pattern of ictal SPECT (22). This result
might be explained by the delayed perfusion change induced
by ictal electrical discharges.
HMPAO versus ECD
Both Tc-99m hexamethylpropylene amine oxime (HMP
AO) ictal SPECT (5) and Tc-99m ethyl cysteinate dimer
(ECD) ictal SPECT (23, 24) were reported to be helpful for
the localization of epileptogenic zones, and one report con-
cluded that Tc-99m ECD compares favorably with unstabi-
lized Tc-99m HMPAO for peri-ictal SPECT studies. Since
ECD is stable after labeling, the latter was believed to have
a distinct advantage of rapid injection at the time of ictus. Re-
cently, however, CoCl2 has been used as a stabilizer for HMP
AO, and when used along with CoCl2, Tc-99m HMPAO was
found to match Tc-99m ECD in terms of the rapidity of its
injection at the time of ictus (26).
The distribution patterns of Tc-99m HMPAO and Tc-99m
ECD were found to be very similar, although the identified
differences may be significant (27, 28). When one considers
the different cellular retention mechanisms of these com-
pounds, a difference in their distribution at the time of ictus
might be expected. 
In an earlier study (29), we replaced Tc-99m HMPAO with
Tc-99m ECD for a period of three months. Before this peri-
od, only Tc-99m HMPAO had been used for ictal perfusion
SPECT. We compared the diagnostic performances of the
two in terms of finding hyperperfused areas and epilepto-
genic zones and the degree of hyperperfusion. We found that
the sensitivity of Tc-99m ECD ictal SPECT was similar to
that of Tc-99m HMPAO ictal SPECT in temporal lobe
epilepsy, however, ictal hyperperfusion was higher for Tc-
99m HMPAO SPECT. In patients with neocortical epilep-
sy, Tc-99m HMPAO ictal SPECT also proved superior to
Tc-99m ECD ictal SPECT in terms of sensitivity and the
degree of hyperperfusion.
Repeated ictal SPECT
For our clinical practice routine these days, the video mo-
nitoring of ictal semiology and EEG covers several episodes
of ictus. This is partly because the ictal EEG at the start of
the ictal discharge may be ambiguous in some episodes, and
also because the observation of multiple episodes enhances
the credibility of the localization of ictal scalp EEG. Ictal
SPECT is usually associated with one ictal episode among
these multiple episodes. It is also not infrequent that multi-
ple foci are found in patients on ictal EEG monitoring.
Peri-ictal propagation of seizure activity complicates the
interpretation of hyperperfused areas, because the seizure activ-
ity can spread to other brain areas within a relatively short
period (30). It is inevitable that unexpected patterns of ictal
hyperperfusion are observed on ictal SPECT. Sometimes no
area of significant hyperperfusion is found on ictal SPECT.
Reproducible observation of ictal cerebral blood flow may
overcome the possible false lateralization or lack of sensitivi-
ty. Repeated ictal SPECT is expected to yield information
that complements the ictal scalp EEG findings (31).
According to a previously reported reproducibility study,
peri-ictal SPECT results were found to be reproducible in
most patients, and this was also corroborated by quantita-
tive subtraction ictal SPECT co-registered to MRI (SISCOM)694 D.S. Lee, S.K. Lee, M.C. Lee
analysis (32). However, the authors considered that the peri-
ictal SPECT images showed decreased perfusion repeatedly
at the epileptogenic zones. Ictal SPECT is usually considered
to be unreliable when it reveals only an area of decreased per-
fusion and not areas of increased perfusion. Efforts to short-
en the injection delay should have been taken in these cases
(20, 32).
Through the investigation on the utility of repeated ictal
SPECT, we found that the repeated ictal SPECT was useful
for yielding new or additional information about the epilep-
togenic zones by confirming that the region of interest was
the epileptogenic zone (Fig. 8) or by suggesting that the
epilepsy was of multifocal origin (31). We suggest that ictal
SPECT should be repeated when the first SPECT findings
are ambiguous. This strategy, which has been adopted in
about 10% of the surgical candidates at our institution over
the past 5 yr, proved to compliment definitely the other im-
proved methodologies, such as the SISCOM or the closer
control to shorten the injection time in epilepsy monitoring
units.
Subtraction SPECT and SPM
Subtraction SPECT (33) or difference SPECT (34) has re-
cently evolved to SISCOM by various investigators (34-36).
While we believe that ictal SPECT images should be closely
compared with interictal SPECT images, traditional side-
to-side visual comparisons of ictal and interictal images (Fig.
9A) may be difficult because of differences in the overall
intensity of both images or differences in slice level and ori-
entation (35). In this sense, computer-aided subtraction of
the interictal SPECT from the ictal SPECT images, with
subsequent co-registration to MRI (Fig. 9B), can overcome
these limitations. Several reports (7, 35, 37) have suggested
that SISCOM should be valid and superior to side-to-side
interpretation.
However, a recent report (38) questioned the usefulness of
ictal-interictal subtraction SPECT and suggested that a nor-
mal population database should be used in interpreting a
patient’ s ictal SPECT. The authors used an automated voxel-
based analysis method to find hyperperfused areas, and found
that the voxel-based automated SPM determination of hy-
perperfused areas (Fig. 9C) was superior to the ictal-interic-
tal subtraction SPECT. As is well known to its advocates,
SISCOM might yield confusing data on areas of hyperperfu-
sion in some cases. These findings are interesting but no de-
finitive explanation has been given to them.
However, there could be several reasons for this observa-
Second (Injection 20 sec) First (Injection 53 sec)
Fig. 8. Repeated ictal SPECT. (A) The first
ictal SPECT. (B) Its SPM result dioes not re-
veal any area of increased perfusion. (C)
The second ictal SPECT. (D) Its SPM result
reveals an area of increased perfusion in
the right temporal lobe.
A B C D
SISCOM SPM
Side-by-side
Fig. 9. (A) Side-by-side examination of ictal
and interictal SPECT, (B) SISCOM and (C)
SPM ictal SPECT result. The right temporal
lobe was found to be epileptogenic.
A
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tion. First, the interictal SPECT may not be actually inter-
ictal. True interictal scans do not always represent the actual
interictal period, and this discrepancy may occur in as many
as 5% of interictal scans, probably due to the injection dur-
ing the subclinical ictal period (38). EEG monitoring and
confirmation of interictal EEG during injection might over-
come this problem, however, our recent investigation (16)
proved that even the interictal injection of radiotracer sever-
al hours after an ictal episode cannot guarantee true interic-
tal images. Late postictal hyperperfusion was found in more
than a half of the patients. We believe that this is the reason
for the prevalence of increased perfusion in the epileptogenic
zones in interictal SPECT. To determine whether the inter-
ictal SPECT represent the true interictal perfusion, subtrac-
tion of interictal from ictal images would be helpful. EEG
monitoring at the time of injection does not convince us that
this SPECT image reflects the true interictal perfusion.
CONCLUSION
Functional neuroimaging methods, such as FDG PET and
ictal perfusion SPECT, are helpful to localize epileptogenic
zones especially in patients with non-lesional epilepsy on
MRI. Quantitative methods, such as SPM, SPAM, and SIS-
COM are believed to be able to enhance the objectivity of
the analysis to find epileptogenic zones by revealing hypo-
metabolic or hyperperfused areas.
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